Wednesday, December 14, 2016

BRIEF-Valeant Pharmaceuticals plans to invest in Salix - CEO

Dec 14 (Reuters) - Valeant Pharmaceuticals International Inc

CEO Joe Papa, speaking at BMO investor conference in

New York:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)